EXACT Therapeutics AS (OSL:EXTX)

Market Cap	107.55M -55.0%
Revenue (ttm)	n/a
Net Income	-72.20M
EPS	-1.44
Shares Out	63.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	17,952
Open	n/a
Previous Close	1.700
Day's Range	n/a
52-Week Range	1.150 - 3.940
Beta	0.23
RSI	39.85
Earnings Date	Apr 8, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 12
• Stock Exchange: Oslo Børs
• Ticker Symbol: EXTX